Pharmas can be 'more than medicine' by focusing on preventative care

The Latest

• 

  Profile

  Jumping into pharma with big plans at a small company

  SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

  Biotech

• 

  Sponsored by ClinicalMind

  3 things medical communications can learn from sales training experts

  Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to "stick".

  Patient

• 

  Podcast

  Woman of the Week: Sparrow Pharmaceuticals' Jamie MacPherson

  The vice president of regulatory affairs and quality on embracing leadership challenges in drug development.

  Biotech

• 

  Q&A

  Biotech Spotlight: Graphite Bio seeks sickle cell cure with a next-gen approach

  Using gene editing, CEO Josh Lehrer says the company is poised to ‘offer a cure’ to a long list of diseases.

  Biotech

• 

  Q&A

  BriOri BioTech sets the stage for the comeback of Vioxx

  With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.

  Patient

• 

  After 40 years, researchers discover new frontiers in the fight against HIV

  Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.

  Biotech

• 

  Are digital DCTs the answer for rare diseases?

  How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.

  Biotech

• 

  Opinion

  Why 'soft' skills matter in the new era of leadership

  Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

  Biotech

• 

  In the hot pharma talent market, execs battle these recruitment misconceptions

  One of the top recruiting firms in life sciences weighs in on how companies can attract the next wave of rising stars.

  Biotech

• 

  Profile

  With the shine of amyloid fading, tau is a rising star in Alzheimer's

  The tau theory in Alzheimer's is being put to the test with phase 3 trial results due later this month from TauRx Pharmaceuticals.

  Biotech

• 

  It's time to acknowledge access as a prescribing barrier

  A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

  Biotech

• 

  Podcast

  Woman of the Week: AiCure's Michelle Marlborough

  As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

  Leadership

• 

  Where hope and uncertainty meet: A cutting-edge cancer developer's winding road

  Replimune is on the precipice of a new kind of cancer treatment, but its CEO knows something about ambiguity.

  Biotech

• 

  FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have

  New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.

  Biotech

• 

  Q&A

  Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

  With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

  Biotech

• 

  Ultra-sensitive tests bring biomarkers into the drug development forefront

  An agreement between the biomarker assay maker Quanterix and pharma giant Eli Lilly could help discover new ways to treat Alzheimer's.

  Biotech

• 

  Pharma's solution to the digital advertising dilemma? Storytelling

  Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

  Biotech

• 

  Profile

  Breaking new ground: Longhorn's trailblazing effort to develop a universal flu vaccine

  After years of success with their diagnostic platform for COVID-19, tuberculosis and the flu, the family funded company is shifting priorities back to the vaccine market.

  Biotech

• 

  Podcast

  Woman of the Week: Amgen's Dr. Jane Parnes

  As executive medical director, early development at Amgen, Dr. Jane Parnes has helped guide clinical research for upwards of 30 of the company’s investigational molecules, including the newly approved Tezspire for severe asthma — one of her career highlights.

  Leadership

• 

  Profile

  Bayer executive makes strides toward a finish line for rare cancers

  Bayer's SVP and general manager of U.S. oncology completed the Boston Marathon to honor his brother and bring attention to rare cancers.

  Leadership

• 

  Profile

  From cancer survivor to clinical trial innovator

  How Alicia Staley is using her insights as a three-time cancer survivor to drive clinical trial improvements at Medidata.

  Patient

• 

  A nuclear threat spurs France's Medesis to advance radiation therapy

  In the event of a nuclear event — intentional or accidental — rapid and widespread deployment of effective treatments is paramount.

  Pharma

• 

  Q&A

  One company's failed drug is this company's 'jewel'

  Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

  Biotech

• 

  The 'innovation gap' haunts Big Pharma, and the race is on for the next blockbusters

  The next big innovation wave is out there, and as pharmas expect massive losses without enough internal R&D to fill those shoes, smaller biotechs beckon.

  Biotech

• 

  Q&A

  How an open platform can shake up the drug development process

  TetraScience’s Alan Millar shares why pharma is rethinking data integration in the race to be faster, better and more effective.

  Pharma

• 

  Profile

  Laura Randa's aim to break down mental healthcare barriers for disabled patients

  Despite the proliferation of mental health apps, many aren’t accessible for people with disabilities. The CEO of Toivoa plans to change that.

  Patient